• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗后局部进展期胃癌手术时间对肿瘤学结果无影响:一项荟萃分析。

Time to surgery does not affect oncologic outcomes in locally advanced gastric cancer after neoadjuvant chemotherapy: a meta-analysis.

机构信息

Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis & Translational Research, Peking University Cancer Hospital & Institute, Beijing, China.

出版信息

Future Oncol. 2023 Feb;19(5):397-408. doi: 10.2217/fon-2022-1061. Epub 2023 Mar 15.

DOI:10.2217/fon-2022-1061
PMID:36919890
Abstract

The authors conducted a meta-analysis to determine the association between time-to-surgery (TTS) after neoadjuvant chemotherapy and patient outcomes in locally advanced gastric cancer. Electronic databases were searched to identify potential studies, in which the authors compared patient outcomes between those with TTS within 4 (and 6) weeks of completion of neoadjuvant chemotherapy and those after 4 (and 6) weeks. Six studies, including 1238 patients, were eligible for inclusion. Pooled data showed no significant differences in rates of pathological complete response, major pathological response, ypN0, complications, R0 resection and operative time between groups of longer TTS and shorter TTS. There was no statistically advantageous impact of prolonged TTS on pathological and surgical outcomes. Large, population-based studies are warranted.

摘要

作者进行了一项荟萃分析,以确定新辅助化疗后手术时间(TTS)与局部晚期胃癌患者结局之间的关系。作者检索电子数据库以确定潜在的研究,其中比较了新辅助化疗完成后 4 (和 6 )周内 TTS 与 4 (和 6 )周后 TTS 的患者结局。纳入了 6 项研究,共 1238 例患者。汇总数据显示,较长 TTS 组和较短 TTS 组之间在病理完全缓解率、主要病理缓解率、ypN0、并发症、R0 切除和手术时间方面无显著差异。TTS 延长对病理和手术结局没有统计学上的有利影响。需要进行大规模的基于人群的研究。

相似文献

1
Time to surgery does not affect oncologic outcomes in locally advanced gastric cancer after neoadjuvant chemotherapy: a meta-analysis.新辅助化疗后局部进展期胃癌手术时间对肿瘤学结果无影响:一项荟萃分析。
Future Oncol. 2023 Feb;19(5):397-408. doi: 10.2217/fon-2022-1061. Epub 2023 Mar 15.
2
[Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].奥沙利铂联合卡培他滨或奥沙利铂联合S-1新辅助化疗治疗进展期胃癌的安全性和有效性
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):138-144. doi: 10.3760/cma.j.cn.441530-20200721-00433.
3
Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis.新辅助化疗后胃癌手术的最佳时机:系统评价和荟萃分析。
World J Surg Oncol. 2023 Dec 1;21(1):377. doi: 10.1186/s12957-023-03251-y.
4
[Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response].[晚期胃癌的新辅助化疗——一例完全缓解病例]
Magy Seb. 2002 Oct;55(5):321-4.
5
[Efficacy of neoadjuvant chemotherpy in patients with locally advanced gastric cancer].新辅助化疗对局部晚期胃癌患者的疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Feb;16(2):166-9.
6
The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis.局部晚期胃及胃食管结合部腺癌的最佳新辅助化疗方案:系统评价和贝叶斯网状meta 分析。
Eur J Med Res. 2022 Nov 9;27(1):239. doi: 10.1186/s40001-022-00878-7.
7
[Thinking of the application of membrane anatomy in gastric cancer surgery after neoadjuvant therapy].[新辅助治疗后膜解剖学在胃癌手术中的应用思考]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jul 25;23(7):657-660. doi: 10.3760/cma.j.cn.441530-20200430-00249.
8
Interval time between neoadjuvant chemotherapy and surgery in advanced gastric cancer doesn't affect outcome: A meta analysis.进展期胃癌新辅助化疗与手术之间的间隔时间不影响预后:一项荟萃分析。
Front Surg. 2023 Jan 16;9:1047456. doi: 10.3389/fsurg.2022.1047456. eCollection 2022.
9
[Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].[应用倾向评分匹配法对局部进展期胃癌新辅助化疗的预后分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1148-1153.
10
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer.一项针对局部晚期胃癌患者的新辅助顺铂-氟尿嘧啶治疗后行术后腹腔内氟尿苷-亚叶酸钙治疗的II期试验。
Ann Oncol. 2006 Sep;17(9):1404-11. doi: 10.1093/annonc/mdl133. Epub 2006 Jun 20.

引用本文的文献

1
Textbook Neoadjuvant Outcome-Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment.教科书式新辅助治疗结局——接受多模式治疗的胃癌患者肿瘤学结局的新型综合测量指标
Cancers (Basel). 2024 Apr 28;16(9):1721. doi: 10.3390/cancers16091721.